Xiancai Ma
- Topics
- HIV Research and Treatment (10 papers)SARS-CoV-2 and COVID-19 Research (5 papers)HIV/AIDS drug development and treatment (4 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Xiancai Ma
25 papers receiving 450 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 240
- Virology 142
- Infectious Diseases 136
- Cancer Research 127
- Immunology 113
Countries citing papers authored by Xiancai Ma
This map shows the geographic impact of Xiancai Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiancai Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiancai Ma more than expected).
Fields of papers citing papers by Xiancai Ma
This network shows the impact of papers produced by Xiancai Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiancai Ma. The network helps show where Xiancai Ma may publish in the future.
Co-authorship network of co-authors of Xiancai Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Xiancai Ma. A scholar is included among the top collaborators of Xiancai Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiancai Ma. Xiancai Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 14 | |
| 8 | 4 | |
| 9 | 10 | |
| 10 | 1 | |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 6 | |
| 14 | 48 | |
| 15 | 33 | |
| 16 | 23 | |
| 17 | 21 | |
| 18 | 149 | |
| 19 | 27 | |
| 20 | 37 |
About Xiancai Ma
Xiancai Ma is a scholar working on Virology, Infectious Diseases and Cancer Research, having authored 28 papers that have together received 457 indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Virology (142 citations), Cancer Research (127 citations) and Infectious Diseases (136 citations). Xiancai Ma has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Hui Zhang, Bingfeng Liu, Yijun Zhang, Weiping Cai, Yue Yin, Jun Li, Guannan Geng, Fudi Zhong, Cancan Chen and Shaoyang Zhang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.